Trials / Conditions / Measurable Residual Disease (MRD)
Measurable Residual Disease (MRD)
3 registered clinical trials studyying Measurable Residual Disease (MRD) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Mu NCT07264010 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Recruiting | Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL NCT06886074 | Hospital Universitario Dr. Jose E. Gonzalez | Phase 2 |
| Completed | Blinatumomab for Treatment of R/R or MRD-positive CD19-Positive MPAL NCT04827745 | University of Maryland, Baltimore | Phase 2 |